Inadequate cortisol response to the tetracosactide (Synacthen®) test in non-classic congenital adrenal hyperplasia: an exception to the rule
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Aims: To describe cortisol response to tetracosactide and to review the literature on adrenal function in non-classic congenital adrenal hyperplasia (NCCAH) patients. Methods: We compared cortisol responses to tetracosactide (250 μg) between NCCAH patients and a comparison group (CG) of patients with premature pubarche and normal tetracosactide test. An adequate cortisol response was defined as a peak ≥18 μg/dl. Results: We included 35 NCCAH patients (26 girls, 9 boys), whose mean age at testing was 7.0 years (0.8-15.6), and 47 patients in the CG (39 girls, 8 boys), whose mean age was 7.2 years (0.5-9.9). Baseline cortisol was significantly higher in the NCCAH group than in the CG [12.9 (4.3-22.2) vs. 9.7 (4.2-16.2) μg/dl, respectively; p = 0.0006]. NCCAH patients had lower cortisol peak response compared to the CG [18.2 (6.3-40) vs. 24.9 (12-30.3) μg/dl, respectively; p < 0.0001]. Peak cortisol was <18 μg/dl in 21/35 (60%) NCCAH patients versus 1/47 (2.1%) in the CG. No NCCAH patients had acute adrenal insufficiency, but 2 reported severe fatigue that improved with hydrocortisone. Conclusions: The cortisol response to tetracosactide was inadequate (<18 μg/dl) in 60% of patients with NCCAH. Hydrocortisone therapy may deserve consideration when major stress (surgery, trauma, childbirth) or objectively documented fatigue occurs in NCCAH patients with inadequate cortisol response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some individuals with NCCAH (60% in one small study) showed an inadequate response to cosyntropin stimulation, but none had frank episodes of adrenal insufficiency (171, 238, 239).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [239]
Citations
Cites
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
High frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
New, M. I., Abraham, M., Gonzalez, B., Dumic, M., Razzaghy-Azar, M., Chitayat, D., Sun, L., Zaidi, M., Wilson, R. C., & Yuen, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300057110 · Cited by 365
Nonclassical 21-Hydroxylase Deficiency
New, M. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1645 · Cited by 315
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Tardy, V., Billaud, L., Laborde, K., Coussieu, C., Morel, Y., Vaury, C., Golmard, J.-L., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1582 · Cited by 213
Self-citationPerry, R., Kecha, O., Paquette, J., Huot, C., Van Vliet, G., & Deal, C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0016 · Cited by 194
Charmandari, E., Hindmarsh, P. C., Johnston, A., & Brook, C. G. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7522 · Cited by 134
Pinto, G., Tardy, V., Trivin, C., Thalassinos, C., Lortat-Jacob, S., Nihoul-Fékété, C., Morel, Y., & Brauner, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021433 · Cited by 101
Self-citationRecommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
Trapp, C. M., & Oberfield, S. E. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.009 · Cited by 81
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital adrenal hyperplasia
Auer, M. K., Nordenström, A., Lajic, S., & Reisch, N. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01330-7 · Cited by 215
Carmina, E., Dewailly, D., Escobar-Morreale, H. F., Kelestimur, F., Moran, C., Oberfield, S., Witchel, S. F., & Azziz, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx014 · Cited by 201
“Risk of adrenal insufficiency As previously reported, there is limited evidence that some patients with NCAH who present with reduced cortisol response to ACTH need glucocorticoid supplementation when undergoing major surgery or if trauma occurs (Stoupa et al., 2015).”
Congenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 184
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Falhammar, H., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0656-0 · Cited by 127
“Nevertheless, they have a partial cortisol insufficiency [14, 32, 51], mostly very mild, but up to one-third of them have an ACTH-stimulated cortisol level below 400 nmol/L and 60 % a level of less than 500 nmol/L.”
BackgroundBiochemical and genetic diagnosis of 21-hydroxylase deficiency
Falhammar, H., Wedell, A., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0731-6 · Cited by 80
Increased Infection Risk in Addison’s Disease and Congenital Adrenal Hyperplasia
Tresoldi, A. S., Sumilo, D., Perrins, M., Toulis, K. A., Prete, A., Reddy, N., Wass, J. A. H., Arlt, W., & Nirantharakumar, K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz006 · Cited by 65
Livadas, S., & Bothou, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00366 · Cited by 57
Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
Adriaansen, B. P. H., Schröder, M. A. M., Span, P. N., Sweep, F. C. G. J., van Herwaarden, A. E., & der Grinten, H. L. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1064024 · Cited by 51
“These findings are in line with the clinical observations that manifestations of cortisol deficiency are uncommon in untreated NCCAH patients (7, 8).”
BackgroundResultNon-Classical Congenital Adrenal Hyperplasia in Childhood
Kurtoğlu, S., & Hatipoğlu, N. (2017) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.3378 · Cited by 49
Russian clinical practice guidelines «congenital adrenal hyperplasia»
Mokrysheva, N. G., Mel'nichenko, G. A., Adamyan, L. V., Troshina, E. A., Молашенко, Н. В., Игоревна, С. А., Uvarova, E. V., Esayan, E. R. M., Andreeva, E. N., Ужегова, Ж. А., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12787 · Cited by 30
Erdeve, Ş. S., Çetinkaya, S. Ç., Abalı, Z. Y., Poyrazoğlu, Ş., Baş, F., Berberoğlu, M., Şıklar, Z., Korkmaz, Ö., Buluş, D., Akbaş, E. D., et al. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0088 · Cited by 21
“[22] also described the cortisol response to tetracosactide in NCCAH patients.”
BackgroundManagement aspects of congenital adrenal hyperplasia during adolescence and transition to adult care
Balagamage, C., Arshad, A., Elhassan, Y., Said, W. B., Krone, R. E., Gleeson, H. K., & Idkowiak, J. (2023) · Clinical Endocrinology · doi:10.1111/cen.14992 · Cited by 19
Chesover, A., Millar, H., Sepiashvili, L., Adeli, K., Palmert, M. R., & Hamilton, J. K. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz030 · Cited by 15
“Children with NCCAH can have glucocorticoid insufficiency (1,4) for which providing glucocorticoid stress dose advice is recommended to reduce the risk of adrenal crisis (2).”
InfluentialDörr, H.-G., Schulze, N., Bettendorf, M., Binder, G., Bonfig, W., Denzer, C., Dunstheimer, D., Salzgeber, K., Schmidt, H., Schwab, K. O., et al. (2020) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-020-00100-w · Cited by 14
Karachaliou, F.-E., Kafetzi, M. L., Dracopoulou, M., Vlachopapadopoulou, E. A., Leka, S., Fotinou, A., & Michalacos, S. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0216 · Cited by 14
Agnani, H., Bachelot, G., Eguether, T., Ribault, B., Fiet, J., Bouc, Y. L., Netchine, I., Houang, M., & Lamazière, A. (2022) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2022.106085 · Cited by 13
Kendırcı, H. N. P., Ünal, E., Dündar, İ., Buluş, A. D., Güneş, S. O., & Şıklar, Z. (2024) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2024.2024-6-26-s · Cited by 11
“Some individuals with NCCAH (60% in a small study) have shown inadequate response to the ACTH stimulation test (stimulated cortisol level less than 500 nmol/L), but overt episodes of adrenal insufficiency have not been observed (82,88,89).”
Kamenický, P., Blanchard, A., Lamazière, A., Piedvache, C., Donadille, B., Duranteau, L., Bry, H., Gautier, J., Salenave, S., Raffin‐Sanson, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz005 · Cited by 11
Bizzarri, C., Chioma, L., Bottaro, G., Paone, L., Todisco, T., Chiarito, M., Surace, C., Porzio, O., D’Alessandro, A., Ravà, L., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02581-w · Cited by 7
Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia
Adriaansen, B. P. H., Utari, A., Olthaar, A. J., van der Steen, R. C. B. M., Pijnenburg-Kleizen, K. J., Berkenbosch, L., Span, P. N., Sweep, F. C. G. J., der Grinten, H. L. C., & van Herwaarden, A. E. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae591 · Cited by 7
Waaijers, S., Utari, A., van der Doelen, R. H. A., Faradz, S. M., Lodewijk, R., Olthaar, A. J., Geutjes, P. J., Sweep, F. C. G. J., der Grinten, H. L. C., & van Herwaarden, A. E. (2022) · Clinical Endocrinology · doi:10.1111/cen.14754 · Cited by 7
“The synacthen test revealed that all the patients in our cohort had an inadequate cortisol response of <240 nmol/L in serum (interquartile range: 64–214 nmol/L; reference value >500 nmol/L).(6,9)”
BackgroundKoren, I., Weintrob, N., Kebesch, R., Majdoub, H., Stein, N., Naor, S., & Segev‐Becker, A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad546 · Cited by 6
Bilici, M. E., Şıklar, Z., Özsu, E., Aycan, Z., Uyanık, R., Ceran, A., & Berberoğlu, M. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251388397 · Cited by 4
The way toward adulthood for females with nonclassic congenital adrenal hyperplasia
Ntali, G., Charisis, S., Kylafi, C. F., Vogiatzi, E., & Michala, L. (2021) · Endocrine · doi:10.1007/s12020-021-02715-z · Cited by 4
Hyperplasie congénitale des surrénales par déficit en 21-hydroxylase
Bachelot, A. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75965-9.00012-x · Cited by 4
Podgórski, R., Podgórska, D., & Sumińska, M. (2023) · Pediatria Polska · doi:10.5114/polp.2023.133534 · Cited by 2
“Nevertheless, the lack of sufficient cortisol rise after adrenocorticotropic hormone (ACTH) stimulation are reported in one-third of NCAH individuals [10].”
BackgroundDörr, H. G., Schulze, N., Bettendorf, M., Binder, G., Bonfig, W., Denzer, C., Dunstheimer, D., Salzgeber, K., Schmidt, H., Schwab, K. O., et al. (2020) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-020-00976-y
Le forme non classiche di iperplasia surrenalica congenita nella donna: diagnosi e terapia
Campioni, L., Carlo, M. C. D., Bergoglio, B., & Giordano, R. (2024) · L Endocrinologo · doi:10.1007/s40619-024-01515-7
“Non esiste alcuna correlazione tra il tipo di risposta di cortisolo al test ACTH, il genotipo e soprattutto le manifestazioni cliniche [18].”
Congenital Adrenal Hyperplasia
Witchel, S. F., Oberfield, S. E., Fisher, A. S., & Trapp, C. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_11
Chagas, N. B. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2024.tde-23012025-094952
Weintrob, N., Segev‐Becker, A., & Koren, I. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf450
Dayno, A. N., Kilberg, M. J., Gonter, E., Gallop, R., Squicciarini, J., Montaño, C., & Vogiatzi, M. G. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1745992
FERREIRA, B., Robin, G., Pigny, P., Bachelot, A., RIBIERE, L., & Catteau-Jonard, S. (2026) · Gynecological Endocrinology · doi:10.1080/09513590.2026.2659979
Medical and social challenges awaiting adolescents with congenital adrenal hyperplasia
Nixon, M., & Davies, J. H. (2026) · Frontiers in Adolescent Medicine · doi:10.3389/fradm.2026.1870467
“Signs of adrenal insufficiency were not observed in a cohort of paediatric NCCAH; and in larger series of older patients, potential features of adrenal insufficiency were observed in only ∼ 1% (8 – 10).”
Chagas, N. B., Moreira, A. C., de Castro, M., & Antonini, S. R. R. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag162
The evolution of new approaches to the treatment of congenital adrenal hyperplasia
Merke, D. P., & Auchus, R. J. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag033
Metadata
- Authors
- Stoupa, A., González-Briceño, L., Pinto, G., Samara-Boustani, D., Thalassinos, C., Flechtner, I., Beltrand, J., Bidet, M., Simon, A., Piketty, M., Laborde, K., Morel, Y., Bellanné-Chantelot, C., Touraine, P., & Polak, M.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Inserm (FR)
- Centre Hospitalier de Versailles (FR)
- Hospices Civils de Lyon (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- ORCID
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 83
- Issue
- 4
- Pages
- 262-267
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W1965724177
- Semantic Scholar
- 38f8861a9749321566f245126ed4114a22980ae4
- Cited by
- 37
- References
- 21
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 5 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 2
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Hormone Research in Paediatrics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Society for Paediatric Endocrinology
- European Society of Endocrinology
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- non-classical congenital adrenal hyperplasia, ACTH stimulation test, cortisol response, adrenal function, premature pubarche, hydrocortisone therapy, fatigue, adrenal crisis, children
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Child, Child, Preschool, Cosyntropin, Female, Humans, Infant, Male, Pituitary-Adrenal Function Tests, Retrospective Studies, Sensitivity and Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.